Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ)
CNY 13.65
(-0.44%)
CNY 13.65
(-0.44%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 134.87 Million CNY | -34.68% |
| 2022 | 206.48 Million CNY | -34.42% |
| 2021 | 314.86 Million CNY | 34.93% |
| 2020 | 233.34 Million CNY | 211.78% |
| 2019 | 74.84 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | -100.0% |
| 2013 | 1.11 Million CNY | -49.71% |
| 2012 | 2.22 Million CNY | -32.6% |
| 2011 | 3.3 Million CNY | -25.0% |
| 2010 | 4.4 Million CNY | -20.0% |
| 2009 | 5.5 Million CNY | -16.66% |
| 2008 | 6.6 Million CNY | -24.98% |
| 2007 | 8.8 Million CNY | 0.0% |
| 2006 | 8.8 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 155.06 Million CNY | 9.36% |
| 2024 Q3 | 199.46 Million CNY | 84.93% |
| 2024 Q1 | 145.52 Million CNY | 33.42% |
| 2023 Q3 | 234.32 Million CNY | -12.83% |
| 2023 Q4 | 134.87 Million CNY | -42.44% |
| 2023 Q1 | 296.32 Million CNY | 43.51% |
| 2023 Q2 | 268.81 Million CNY | -9.28% |
| 2023 FY | 134.87 Million CNY | -34.68% |
| 2022 FY | 206.48 Million CNY | -34.42% |
| 2022 Q3 | 174.09 Million CNY | -31.5% |
| 2022 Q2 | 254.15 Million CNY | -15.5% |
| 2022 Q4 | 206.48 Million CNY | 18.6% |
| 2022 Q1 | 300.76 Million CNY | -4.48% |
| 2021 Q2 | 343.85 Million CNY | -1.72% |
| 2021 Q4 | 314.86 Million CNY | 0.77% |
| 2021 FY | 314.86 Million CNY | 34.93% |
| 2021 Q1 | 349.87 Million CNY | 49.94% |
| 2021 Q3 | 312.45 Million CNY | -9.13% |
| 2020 Q1 | 125.97 Million CNY | 68.32% |
| 2020 Q3 | 219.98 Million CNY | 25.8% |
| 2020 Q4 | 233.34 Million CNY | 6.07% |
| 2020 Q2 | 174.86 Million CNY | 38.81% |
| 2020 FY | 233.34 Million CNY | 211.78% |
| 2019 Q1 | 71.01 Thousand CNY | 0.0% |
| 2019 FY | 74.84 Million CNY | 0.0% |
| 2019 Q4 | 74.84 Million CNY | 177.81% |
| 2019 Q3 | 26.94 Million CNY | 0.0% |
| 2019 Q2 | - CNY | -100.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 FY | - CNY | -100.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2013 Q2 | 2.24 Million CNY | -0.14% |
| 2013 Q1 | 2.25 Million CNY | 1.07% |
| 2013 Q3 | 2.24 Million CNY | 0.02% |
| 2013 Q4 | 1.11 Million CNY | -50.19% |
| 2013 FY | 1.11 Million CNY | -49.71% |
| 2012 Q3 | 3.32 Million CNY | 0.0% |
| 2012 FY | 2.22 Million CNY | -32.6% |
| 2012 Q1 | 3.3 Million CNY | -0.01% |
| 2012 Q2 | - CNY | -100.0% |
| 2012 Q4 | 2.22 Million CNY | -33.11% |
| 2011 FY | 3.3 Million CNY | -25.0% |
| 2011 Q4 | 3.3 Million CNY | -24.92% |
| 2011 Q2 | 4.43 Million CNY | 0.81% |
| 2011 Q1 | 4.4 Million CNY | -0.1% |
| 2011 Q3 | 4.4 Million CNY | -0.81% |
| 2010 FY | 4.4 Million CNY | -20.0% |
| 2010 Q1 | 5.54 Million CNY | 0.76% |
| 2010 Q4 | 4.4 Million CNY | -20.54% |
| 2010 Q3 | 5.54 Million CNY | 0.02% |
| 2010 Q2 | 5.54 Million CNY | -0.09% |
| 2009 FY | 5.5 Million CNY | -16.66% |
| 2009 Q3 | 6.76 Million CNY | 1.64% |
| 2009 Q4 | 5.5 Million CNY | -18.61% |
| 2009 Q2 | 6.65 Million CNY | 0.0% |
| 2008 Q4 | 6.6 Million CNY | 0.0% |
| 2008 FY | 6.6 Million CNY | -24.98% |
| 2007 FY | 8.8 Million CNY | 0.0% |
| 2006 FY | 8.8 Million CNY | 0.0% |